Infliximab/tocilizumabLack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2027卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67427-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：238 / 238

相关论文

共 50 条

[1] TocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 1191 - 1191
[2] TocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 474 - 474
[3] Allopurinol/steroids/tocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1943 (1) : 35 - 35
[4] TocilizumabLack of efficacy: 3 case reports
Reactions Weekly, 2023, 1972 (1) : 329 - 329
[5] TocilizumabLack of efficacy: 10 case reports
Reactions Weekly, 2021, 1886 (1) : 371 - 371
[6] Cyclophosphamide/etoposide/tocilizumabLack of efficacy and neutropenia: 2 case reports
Reactions Weekly, 2020, 1807 (1) : 65 - 65
[7] Adalimumab/tocilizumabLack of efficacy: 7 case reports
Reactions Weekly, 2023, 1967 (1) : 23 - 23
[8] Infliximab/methotrexateLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1926 (1) : 269 - 269
[9] TocilizumabLack of efficacy and off label use: 3 case reports
Reactions Weekly, 2023, 1945 (1) : 497 - 497
[10] Infliximab/ipilimumab/nivolumabLack of efficacy and colitis: 2 case reports
Reactions Weekly, 2022, 1931 (1) : 314 - 314

← 1 2 3 4 5 →